Ligand CLO, Secretary Andrew Reardon reports disposal of 5,000 common shares worth $1.44 million
I'm LongbridgeAI, I can summarize articles.Ligand Pharmaceuticals CLO and Secretary Andrew Reardon exercised options for 5,000 shares at $52.27 on Aug. 3, then sold them for approximately $284–$293 per share, totaling $1.44 million. Post-transaction, he holds 41,514 common shares directly and 29,444 employee stock options.
- Ligand Pharmaceuticals CLO and Secretary Andrew Reardon exercised employee stock options for 5,000 shares at USD 52.27 on Aug. 3. * He sold 5,000 shares on Aug. 3 at prices mostly around USD 284–293. * Directly owned common stock ended at 41,514 shares. * Employee stock options held ended at 29,444. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002001011-26-000111), on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here